Literature DB >> 7824068

Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices.

S G Norman1, G V Johnson.   

Abstract

Mitochondria play an important role in modulating intracellular levels of calcium, and therefore compromised mitochondrial function often leads to disruptions in calcium homeostasis. In this study, the effects of two uncouplers of oxidative phosphorylation, carbonyl cyanide-3-chlorophenylhydrazone (CCCP) and p-trifluoromethoxyphenylhydrazone (FCCP), on calcium-mediated modifications of the microtubule-associated protein, tau, in rat brain slices were examined. Incubation of slices with CCCP or FCCP resulted in an increase in electrophoretic mobility of several of the tau isoforms, with no apparent loss of intact tau or the appearance of degradation products. These data indicated that disrupting mitochondrial function by dissipating the transmembrane potential resulted in the dephosphorylation of tau. This finding was confirmed by using a front phosphorylation assay to demonstrate a CCCP-induced decrease in the phosphorylation state of tau. The dephosphorylation of tau induced by the proton-ionophores appeared to be calcium-dependent since the effect was blocked by EGTA. In addition, the CCCP-induced dephosphorylation of tau was blocked by cyclosporin A, a selective inhibitor of the calcium-dependent phosphatase, calcineurin. These data strongly indicate that tau is a substrate for calcineurin in vivo. Finally, the levels of ATP were depleted to a similar extent in brain slices incubated in the presence of CCCP or CCCP and EGTA. These results demonstrated depletion of ATP alone was not sufficient to stimulate the dephosphorylation of tau in this experimental paradigm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824068     DOI: 10.1007/bf00965149

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

Review 1.  Tau protein and the establishment of an axonal morphology.

Authors:  K S Kosik; A Caceres
Journal:  J Cell Sci Suppl       Date:  1991

2.  Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease.

Authors:  W K Liu; W T Moore; R T Williams; F L Hall; S H Yen
Journal:  J Neurosci Res       Date:  1993-02-15       Impact factor: 4.164

3.  Reorganization of HeLa cell cytoskeleton induced by an uncoupler of oxidative phosphorylation.

Authors:  B Maro; M Bornens
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

4.  Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin.

Authors:  S Goto; H Yamamoto; K Fukunaga; T Iwasa; Y Matsukado; E Miyamoto
Journal:  J Neurochem       Date:  1985-07       Impact factor: 5.372

Review 5.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

6.  p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected].

Authors:  M Goedert; E S Cohen; R Jakes; P Cohen
Journal:  FEBS Lett       Date:  1992-11-02       Impact factor: 4.124

7.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

8.  Mitochondrial genetics: a paradigm for aging and degenerative diseases?

Authors:  D C Wallace
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

9.  Ca(2+)-dependent and independent mitochondrial damage in hepatocellular injury.

Authors:  G Bellomo; R Fulceri; E Albano; A Gamberucci; A Pompella; M Parola; A Benedetti
Journal:  Cell Calcium       Date:  1991-05       Impact factor: 6.817

10.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  3 in total

1.  Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.

Authors:  Ana Lloret; Mari-Carmen Badia; Esther Giraldo; Gennady Ermak; Maria-Dolores Alonso; Federico V Pallardó; Kelvin J A Davies; Jose Viña
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease.

Authors:  Marcel V Alavi
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-08-13       Impact factor: 4.739

3.  NBR1 is dispensable for PARK2-mediated mitophagy regardless of the presence or absence of SQSTM1.

Authors:  J Shi; G Fung; H Deng; J Zhang; F C Fiesel; W Springer; X Li; H Luo
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.